Trial Profile
Randomized Phase II study of Vinorelbine Maintenance therapy vs Best Supportive Care in Advanced Non Small Cell Lung Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Mar 2018
Price :
$35
*
At a glance
- Drugs Vinorelbine (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 22 Feb 2018 Status changed from recruiting to completed.
- 30 Sep 2016 New trial record